Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 57 positions. The ten largest identified positions carry 42.8% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc RVMD | Healthcare | United States | 7.72% | $13.61M |
| 2 | Eli Lilly & Co LLY | Healthcare | United States | 4.82% | $8.49M |
| 3 | Roche Holding AG | — | Switzerland | 4.21% | $7.42M |
| 4 | Cogent Biosciences Inc COGT | Healthcare | United States | 4.09% | $7.21M |
| 5 | Novartis AG | — | Switzerland | 4.02% | $7.09M |
| 6 | Immunome Inc IMNM | Healthcare | United States | 3.91% | $6.89M |
| 7 | Celcuity Inc CELC | Healthcare | United States | 3.57% |
Source: SEC filings. Information and analytics, not investment advice.
| $6.30M |
| 8 | Merck & Co Inc MRK | Healthcare | United States | 3.57% | $6.28M |
| 9 | AstraZeneca PLC AZN | Healthcare | United Kingdom | 3.53% | $6.22M |
| 10 | Nuvalent Inc | — | United States | 3.36% | $5.93M |
| 11 | Bristol-Myers Squibb Co BMY | Healthcare | United States | 3.30% | $5.81M |
| 12 | Legend Biotech Corp LEGN | Healthcare | United States | 2.99% | $5.27M |
| 13 | AbbVie Inc ABBV | Healthcare | United States | 2.80% | $4.94M |
| 14 | Exelixis Inc EXEL | Healthcare | United States | 2.77% | $4.89M |
| 15 | Bridgebio Pharma Inc BBIO | Healthcare | United States | 2.75% | $4.84M |
| 16 | Johnson & Johnson JNJ | Healthcare | United States | 2.54% | $4.48M |
| 17 | CG oncology Inc CGON | Healthcare | United States | 2.42% | $4.27M |
| 18 | Genmab A/S GMAB | Healthcare | Denmark | 2.37% | $4.18M |
| 19 | Ideaya Biosciences Inc IDYA | Healthcare | United States | 2.27% | $4.00M |
| 20 | Amgen Inc AMGN | Healthcare | United States | 2.10% | $3.71M |
| 21 | Zai Lab Ltd ZLAB | Healthcare | China | 1.97% | $3.48M |
| 22 | BeOne Medicines Ltd ONC | Healthcare | United States | 1.88% | $3.31M |
| 23 | Zymeworks Inc ZYME | Healthcare | United States | 1.50% | $2.65M |
| 24 | Enliven Therapeutics Inc ELVN | Healthcare | United States | 1.30% | $2.30M |
| 25 | Relay Therapeutics Inc RLAY | Healthcare | United States | 1.28% | $2.26M |